Big Move For Forward Pharma A/S
Wed 11 Dec 19 at 05:30 PM
Forward Pharma A/S (FWP:NASDAQ) soared at $9.6, representing a gain of 69.9%. On Tue 10 Dec 19, FWP:NASDAQ touched a New 2-Week Intraday High of $5.72.
About Forward Pharma A/S (FWP:NASDAQ)
Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients.
Top 10 Gainers:
- CTI Industries Corporation (CTIB:NASDAQ), 150.81%
- DPW Holdings, Inc. (DPW:NYSEMKT), 82.39%
- Forward Pharma A/S (FWP:NASDAQ), 69.91%
- Camber Energy, Inc. (CEI:NYSEMKT), 69.42%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 40.72%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 37.98%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 31.4%
- Immunic, Inc. (IMUX:NASDAQ), 24.62%
- Centogene N.V. (CNTG:NASDAQ), 23.76%
- Neon Therapeutics, Inc. (NTGN:NASDAQ), 23.64%